Report Overview:
The Global Nanomedicine Market achieved a valuation of $188.05 Billion in 2022 and is anticipated to exceed $366.53 Billion by 2030, reflecting a compounded annual growth rate (CAGR) of 8.7% during the forecast period from 2024 to 2032.
Key Market Players:
Abbott Laboratories, DiaSorin S.P.A., General Electric Company, Invitae Corporation, Johnson &...
English
Arabic
French
Spanish
Portuguese
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek